Bone Cements Based on Struvite: The Effect of Vancomycin Loading and Assessment of Biocompatibility and Osteoconductive Potentials In Vivo

2021 ◽  
Vol 66 (8) ◽  
pp. 1079-1090
Author(s):  
P. A. Krokhicheva ◽  
M. A. Gol’dberg ◽  
D. R. Khairutdinova ◽  
O. S. Antonova ◽  
S. A. Akhmedova ◽  
...  
Keyword(s):  
2019 ◽  
Vol 76 ◽  
pp. 513-521 ◽  
Author(s):  
Shan Gao ◽  
Yang Lv ◽  
Liang Yuan ◽  
Huihui Ren ◽  
Teng Wu ◽  
...  

2005 ◽  
Vol 99 (3) ◽  
pp. 443-448 ◽  
Author(s):  
G.T. Ensing ◽  
B.L. Roeder ◽  
J.L. Nelson ◽  
J.R. Horn ◽  
H.C. der Mei ◽  
...  

RSC Advances ◽  
2016 ◽  
Vol 6 (111) ◽  
pp. 109414-109424 ◽  
Author(s):  
Madison A. P. McEnery ◽  
Sichang Lu ◽  
Mukesh K. Gupta ◽  
Katarzyna J. Zienkiewicz ◽  
Joseph C. Wenke ◽  
...  

Oxidatively degradable bone cements exhibit bone-like strength and remodel to form new bone in vivo.


Author(s):  
Oleg Vyrva ◽  
Olexii Goncharuk ◽  
Natalia Lysenko

Current article is a review of experimental studies of different bone cements types and their combinations. Providing of bone fragments  stable fixation  at osteosynthesis  in cases of difficult multifragmental fractures, arthroplasties and other implants using especially in the osteoporosis conditions is a main task of orthopaedic surgery procedures. Polymethylmethacrylate (PMMA) is the first material that is answered to these requirements. The evolution of bone cements resulted in creation of a new composite substance — combination of PMMA and β-threecalciumphosfates (β-TCPh). Combination of these two components allowed to provide high bioabsorbal, osteoconductive and osteointegrative properties along with sufficient durability. In the analyzed works the properties of composite cement CalCemex were evaluated in vivo experiment. It was found that in the case of PMMA penetration of bone tissue into the polymer structure did not occur. Under the conditions of using bone cement with β-TCF admixture, the formation of bone tissue was observed not only on the surface of the implant, but also in the external and internal pores. It is the presence of pores in CalCemex that the authors explain the possibility of penetration of cellular elements, blood vessels and bone formation. Moreover, β-TCPh is included into this material and it is bioresorbed by osteoclasts. This leads to the release of calcium and phosphorus ions and, consequently, simplifies the attachment of the newly formed bone to the bone cement. We assume that composite cement like CalCemex type is a promising material for the treatment of various types of fractures and replacement of bone defects. It should be mentioned that research in this area is ongoing and intensive work is underway to synthesize and study the results of clinical application of composite bone cements with maximum bioactive properties that will not only strengthen bone tissue but also perform osteointegrative function. Key words. Bone cement, polymethylmethacrylate, β-threecalciumphosfates, experiment.


Author(s):  
F C M Driessens ◽  
J A Planell ◽  
M G Boltong ◽  
I Khairoun ◽  
M P Ginebra

Calcium phosphate bone cements (CPBCs) are osteotransductive, i.e. after implantation in bone they are transformed into new bone tissue. Furthermore, due to the fact that they are mouldable, their osteointegration is immediate. Their chemistry has been established previously. Some CPBCs contain amorphous calcium phosphate (ACP) and set by a sol-gel transition. The others are crystalline and can give as the reaction product dicalcium phosphate dihydrate (DCPD), calcium-deficient hydroxyapatite (CDHA), carbonated apatite (CA) or hydroxyapatite (HA). Mixed-type gypsum-DCPD cements are also described. In vivo rates of osteotransduction vary as follows: gypsum-DCPD > DCPD > CDHA ≍ CA > HA. The osteotransduction of CDHA-type cements may be increased by adding dicalcium phosphate anhydrous (DCP) and/or CaCO3 to the cement powder. CPBCs can be used for healing of bone defects, bone augmentation and bone reconstruction. Incorporation of drugs like antibiotics and bone morphogenetic protein is envisaged. Load-bearing applications are allowed for CDHA-type, CA-type and HA-type CPBCs as they have a higher compressive strength than human trabecular bone (10 MPa).


RSC Advances ◽  
2016 ◽  
Vol 6 (1) ◽  
pp. 586-596 ◽  
Author(s):  
Miao Sun ◽  
An Liu ◽  
Chiyuan Ma ◽  
Huifeng Shao ◽  
Menghua Yu ◽  
...  

Herein we systematically investigated the biological performance of a β-dicalcium silicate (β-C2S)-based bone cement in comparison with the clinically used calcium phosphate cement (CPC) and Bio-Oss®.


2011 ◽  
Vol 493-494 ◽  
pp. 403-408
Author(s):  
H.A.I. Cardoso ◽  
M. Motisuke ◽  
A.C.D. Rodas ◽  
O.Z. Higa ◽  
Cecília A.C. Zavaglia

An application of calcium phosphates is as bone cements, among which the system based on alpha-tricalcium phosphate (α-TCP) exhibits excellent properties. The aim of this study is to analyze pH evolution and cytotoxicity of α-TCP cement with three different additives. Changes on the pH were measured at intervals of 12h during seven days. But initial measurements were executed at each 15 minutes. Indirect cytotoxicity test was performed according to ISO (10993-5, 1992) employing CHO-k1 cells and RPMI 1640 as culture medium. It was used a colorimetric method which uses the tetrazolium compound. The additives used on the liquid phase were disodium hydrogen phosphate (Na2HPO4) and/or citric acid (C6H8O7) and/or tannic acid (C76H52O46). The results indicate that the cement without additives does not have requirements to be applied like bone cement, while the other cements composition exhibit different responses in the pH and the cytotoxicity test. In conclusion, due to the presence of additives it was possible to control pH evolution during setting and cytotoxic response. However, further investigation is necessary in order to determine the influence of these additives, mainly tannic acid, on the in vivo behavior of these bone cements.


2001 ◽  
Vol 217 (1-2) ◽  
pp. 57-69 ◽  
Author(s):  
Susana Torrado ◽  
Paloma Frutos ◽  
Gloria Frutos

Sign in / Sign up

Export Citation Format

Share Document